[Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics].
Gasquet
I
I
Bouhassira
M
M
Launois
R
R
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations